Sequencing Consumables Market Size, Share, and Trends 2024 to 2034

The global sequencing consumables market size is evaluated at USD 15.70 billion in 2025 and is forecasted to hit around USD 55.13 billion by 2034, growing at a CAGR of 17.15% from 2025 to 2034. The North America market size was accounted at USD 5.89 billion in 2024 and is expanding at a CAGR of 17.18% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : February 2025
  • Report Code : 3679
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Sequencing Consumables Market 

5.1. COVID-19 Landscape: Sequencing Consumables Industry Impact

5.2. COVID-19 - Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Sequencing Consumables Market, By Product

8.1. Sequencing Consumables Market Revenue and Volume, by Product

8.1.1 Kits

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Reagents

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Accessories

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Sequencing Consumables Market, By Platform

9.1. Sequencing Consumables Market Revenue and Volume, by Platform

9.1.1. 1st Generation sequencing consumables

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. 2nd Generation sequencing consumables

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. 3rd Generation sequencing consumables

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Sequencing Consumables Market, By Application 

10.1. Sequencing Consumables Market Revenue and Volume, by Application

10.1.1. Cancer Diagnostics

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Infectious Disease Diagnostics

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Reproductive Health Diagnostics

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Pharmacogenomics

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Agrigenomics

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Others

10.1.6.1. Market Revenue and Volume Forecast

Chapter 11. Global Sequencing Consumables Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product

11.1.2. Market Revenue and Volume Forecast, by Platform

11.1.3. Market Revenue and Volume Forecast, by Application

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product

11.1.4.2. Market Revenue and Volume Forecast, by Platform

11.1.4.3. Market Revenue and Volume Forecast, by Application

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product

11.1.5.2. Market Revenue and Volume Forecast, by Platform

11.1.5.3. Market Revenue and Volume Forecast, by Application

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product

11.2.2. Market Revenue and Volume Forecast, by Platform

11.2.3. Market Revenue and Volume Forecast, by Application

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product

11.2.4.2. Market Revenue and Volume Forecast, by Platform

11.2.4.3. Market Revenue and Volume Forecast, by Application

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product

11.2.5.2. Market Revenue and Volume Forecast, by Platform

11.2.5.3. Market Revenue and Volume Forecast, by Application

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product

11.2.6.2. Market Revenue and Volume Forecast, by Platform

11.2.6.3. Market Revenue and Volume Forecast, by Application

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product

11.2.7.2. Market Revenue and Volume Forecast, by Platform

11.2.7.3. Market Revenue and Volume Forecast, by Application

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product

11.3.2. Market Revenue and Volume Forecast, by Platform

11.3.3. Market Revenue and Volume Forecast, by Application

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product

11.3.4.2. Market Revenue and Volume Forecast, by Platform

11.3.4.3. Market Revenue and Volume Forecast, by Application

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product

11.3.5.2. Market Revenue and Volume Forecast, by Platform

11.3.5.3. Market Revenue and Volume Forecast, by Application

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product

11.3.6.2. Market Revenue and Volume Forecast, by Platform

11.3.6.3. Market Revenue and Volume Forecast, by Application

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product

11.3.7.2. Market Revenue and Volume Forecast, by Platform

11.3.7.3. Market Revenue and Volume Forecast, by Application

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product

11.4.2. Market Revenue and Volume Forecast, by Platform

11.4.3. Market Revenue and Volume Forecast, by Application

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product

11.4.4.2. Market Revenue and Volume Forecast, by Platform

11.4.4.3. Market Revenue and Volume Forecast, by Application

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product

11.4.5.2. Market Revenue and Volume Forecast, by Platform

11.4.5.3. Market Revenue and Volume Forecast, by Application

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product

11.4.6.2. Market Revenue and Volume Forecast, by Platform

11.4.6.3. Market Revenue and Volume Forecast, by Application

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product

11.4.7.2. Market Revenue and Volume Forecast, by Platform

11.4.7.3. Market Revenue and Volume Forecast, by Application

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product

11.5.2. Market Revenue and Volume Forecast, by Platform

11.5.3. Market Revenue and Volume Forecast, by Application

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product

11.5.4.2. Market Revenue and Volume Forecast, by Platform

11.5.4.3. Market Revenue and Volume Forecast, by Application

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product

11.5.5.2. Market Revenue and Volume Forecast, by Platform

11.5.5.3. Market Revenue and Volume Forecast, by Application

Chapter 12. Company Profiles

12.1. Illumina, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Thermo Fisher Scientific Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Qiagen N.V

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. F. Hoffmann-La Roche Ltd.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Agilent Technologies, Inc

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Pacific Biosciences of California, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. PerkinElmer, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Oxford Nanopore Technologies Ltd.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Bio-Rad Laboratories, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. BGI Genomics Co., Ltd.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global sequencing consumables market size is expected to increase USD 55.13 billion by 2034 from USD 11.32 billion in 2024.

The global sequencing consumables market will register growth rate of 17.15% between 2025 and 2034.

The major players operating in the sequencing consumables market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Pacific Biosciences of California, Inc. (US), PerkinElmer, Inc. (US), Oxford Nanopore Technologies Ltd. (UK), Bio-Rad Laboratories, Inc. (US), BGI Genomics Co., Ltd. (China), GenScript Biotech Corporation (China), Eurofins Scientific (Luxembourg), Macrogen Inc. (South Korea), New England Biolabs, Inc. (US), Swift Biosciences, Inc. (US) and Othees.

The driving factors of the sequencing consumables market are the advancements in sequencing technologies and increasing integration of genomics into healthcare practices fuels.

North America region will lead the global sequencing consumables market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client